Tang Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Tang Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-411,968	Closed	-$8.9M	–	125
2022 Q4	$8.9M	Sell	411,968 -687,548	-63%	-$14.5M	1.29%	23
2022 Q3	$21.3M	Buy	1,099,516 +399,516	+57%	+$8.26M	2.61%	10
2022 Q2	$13.9M	Buy	700,000 +232,298	+50%	+$6.13M	2.11%	17
2022 Q1	$14M	Buy	+467,702	New	+$13.7M	2.79%	11

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tang Capital Management's ALBO Position: Q1 2023 in Review

Tang Capital Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 411,968 shares — an estimated $8.9M sold.

Tang Capital Management first reported a position in ALBO in Q1 2022 and held it in 4 quarters. The position peaked at $21.3M in Q3 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Tang Capital Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Tang Capital Management sold 411,968 Albireo Pharma Inc shares in Q1 2023, an estimated $8.9M.
Tang Capital Management first reported a position in Albireo Pharma Inc in Q1 2022 and held it in 4 quarters.
Tang Capital Management's Albireo Pharma Inc position peaked at $21.3M in Q3 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Tang Capital Management's 13F filing for Q1 2023, filed 15 May 2023.